No Prescription Pharmacy |
 |
 | ||
|
Lithicarb Eskalith |
|
| ||
Home » Prescription Drugs 10 » Lithicarb Eskalith Indications1.Treatment of mania and hypomania. 2.Lithium may also be tried in the treatment of some patients with recurrent bipolar depression for which treatment with other antidepressants has been unsuccessful. 3.Prophylactic treatment of recurrent affective disorders.Dosage and AdministrationA simple treatment schedule has been evolved which except for some minor variations should be followed whether using LITHICARB FC therapeutically or prophylactically. The minor variations to this schedule depend on the elements of the illness being treated and these are described later.1. In patients of average weight (70kg) an initial dose of 400- 1 200mg of LITHICARB FC may be given as a single daily dose in the morning or on retiring. Alternatively the dose may be divided and given morning and evening. The tablets should not be crushed chewed or swallowed with hot liquids. When changing from other lithium preparations serum lithium levels should first be checked then 2. LITHICARB FC therapy commenced at a daily dose as close as possible to the dose of the other form of lithium. As bioavailability varies from product to product (particularly with regard to retard or slow release preparations) a change of product should be regarded as initiation of new treatment. 3. Four to five days after starting treatment (and never longer than one week) a blood sample should be taken for the estimation of serum lithium level. 4. The objective is to adjust the LITHICARB FC dose so as to maintain the serum lithium level permanently within the diurnal range of 0.5 - 1.5 mmol/L. In practice the blood sample should be taken between 12 and 24 hours after the previous dose of LITHICARB FC. 'Target' serum lithium concentrations at 12 and 24 hours are shown in Table 1.LITHICARB FC tablets are scored therefore they can be divided accurately to provide dosage adjustments as small as 125mg. Serum lithium levels should be monitored weekly until stabilisation is achieved.Table 1. Target serum lithium concentrations "Target" serum lithium concentration (mmol/L) At 12 hours At 24 hours Once daily dosage 0.7 - 1.0 0.5 - 0.8 Twice daily dosage 0.5 - 0.8 4. Lithium therapy should not be initiated unless adequate facilities for routine monitoring of serum concentrations are available. Following stabilisation of serum lithium levels the period between subsequent estimations can be increased gradually but should not normally exceed three months. Additional measurements should be made following alteration of dosage on development of intercurrent disease signs of manic or depressive relapse following significant change in sodium or fluid intake or if signs of lithium toxicity occur. 5. Whilst a high proportion of acutely ill patients may respond within three to seven days of the commencement of LITHICARB FC therapy LITHICARB FC should be continued through any recurrence of the affective disturbance. This is important as the full prophylactic effect may not occur for 6 to 12 months after the initiation of therapy. 6. In patients who show a positive response to LITHICARB FC therapy treatment is likely to be long term. Careful clinical appraisal of the patient should be exercised throughout medication (see Precautions).Treatment of Acute Mania Hypomania and Recurrent Bipolar Depression:It is likely that a higher than normal LITHICARB FC intake may be necessary during an acute phase and divided doses would be required here. Therefore as soon as control of mania or depression is achieved the serum lithium level should be determined and it may be necessary dependent on the results to lower the dose of LITHICARB FC and re-stabilise serum lithium levels. In all other details the described treatment schedule is recommended.Prophylactic Treatment of Recurrent Affective DisordersIt is recommended that the described treatment schedule is followed.Use in the Elderly:In elderly patients or those below 50kg in weight it is recommended that the starting dose be 400mg. Elderly patients may be more sensitive to undesirable effects of lithium and may also require lower doses in order to maintain normal serum lithium levels. It follows therefore that long term patients often require a reduction in dosage over a period of years.Use in Children and AdolescentsNot recommended. Buy Lithicarb Eskalith and other Prescription Drugs 10 products online at Medstore. Buy Online at Medstore - Click Here!
About Lithicarb Eskalith: Product Type: Prescription Drugs 10 Lithicarb ( Eskalith Generic Lithium Carbonate ) Lithicarb (Eskalith Generic Lithium Carbonate) Eskalith Generic Lithium Carbonate 250mg Eskalith Generic Lithium Carbonate Lithicarb
View more Prescription Drugs 10 No Prescription Pharmacy:
Medstore Discount Prescription Information : What is the maximum amount I can charge to my credit card? There is a maximum of $500.00usd that can be charged to a credit card for a single transaction. Any attempt to charge an amount in excess of this will result in a declined error. If this happens please reduce the order to be within the $500.00usd limit.
I have no response to my email address? Customers who have an aol.com, comcast.net or earthlink.net e-mail address may have difficulty receiving our e-mail confirmations due to the spam filters which are run by these providers. If possible, please supply an alternative e-mail address.
What are the drugs you source for us? All drugs that we offer on this site are in their generic form, and listed by their brand name. Every drug in existence is given a generic name upon its creation. The most popular and mass marketed drugs are then given a copyright brand or trade name for sales purposes. This is very similar to the way actors use a stage name. Just as the actor is one person with two names, these drugs are one chemical with two names. Stage names and brand names serve the same purpose, for the public to identify and easily remember the specific drug. Our drugs are manufactured in India, home to an enormous pharmaceutical industry, largely owned and operated by US drug companies. Under international law, Indian patent law allows scientists to reverse-engineer the active molecule of brand name drugs using a different process than the original patent, thereby allowing these manufacturers to obtain a process patent of their own. These drugs, legally made and patented in India without huge development and advertising costs, can be sold legally worldwide, at a fraction of the cost of the name brand they duplicate.
| ||
